Vimarsana
Biggest News Aggregation in the World

Page 50 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compugen Today - Breaking & Trending Today

Mutant gene-targeted immunotherapy approach developed - Vimarsana News

Mutant gene-targeted immunotherapy approach developed

Two of the three research studies -- led by Jacqueline Douglass, M.D., Ph.D. candidate at the Johns Hopkins University School of Medicine and Emily Han-Chung Hsiue, M.D., Ph.D., postdoctoral fellow at Johns Hopkins--report on a precision medicine immunotherapy approach that specifically kills cancer cells by targeting mutant protein fragments presented as antigens on the cancer cell surface. Although common across cancer types, p53 mutations have not been successfully targeted with drugs. Genetic alterations in tumor suppressor genes often resulted in their functional inactivation. "Tradition...

Compugen: 4Q Earnings Snapshot - Vimarsana News

Compugen: 4Q Earnings Snapshot

HOLON, Israel (AP) _ Compugen Ltd. (CGEN) on Thursday reported a loss of $8.6 million in its fourth quarter. The Holon, Israel-based company said it had a loss of 10 cents per...

Source: apnews.com
Compugen Reports Fourth Quarter and Full Year 2020 Results - Vimarsana News

Compugen Reports Fourth Quarter and Full Year 2020 Results

Compugen Reports Fourth Quarter and Full Year 2020 Results USA - English Encouraging signals of anti-tumor activity demonstrated across COM701 Phase 1 combination and monotherapy studies with durable responses, including a complete response, in tumor types typically unresponsive to checkpoint inhibitors Expansion of DNAM axis clinical programs to include Phase 1b cohort expansion of COM701 with Opdivo® in Q2 2021 and Phase 1 COM701 with COM902 dual combination study in 2H 2021 Initial data from ongoing dose escalation studies of triple combination of COM701 with Bristol Myers Squibb's Opdivo...

Record redemption in Ark ETF sparks liquidity worries - Vimarsana News

Record redemption in Ark ETF sparks liquidity worries

A record half-billion dollar redemption from Ark Invest's flagship fund in a single day has led analysts to highlight the risks arising from the ETF's heavy exposure to illiquid stocks if outflows pick up pace.

Conexiom Announces EMEA Expansion, Adds VP, Dominic Aelberry - Vimarsana News

Conexiom Announces EMEA Expansion, Adds VP, Dominic Aelberry

Conexiom Announces EMEA Expansion, Adds VP, Dominic Aelberry Leading sales order and invoice automation platform makes significant investment in Europe and the UK LONDON--(BUSINESS WIRE)--Conexiom, the leading provider of sales order and invoice automation solutions, today announces a key step in accelerating growth in Europe and the UK. Industry veteran Dominic Aelberry has been appointed Vice President of UK and EMEA. Aelberry will work with UK and European customers to help them drive greater revenue, reduce costs, and deliver superior customer experiences. "Our customers are using our aut...